Patent ID: 9694003
Date: 2017-07-04
CPC Classifications: A61K,A61P

Claim:
1. A method of treating a mammal in need of a reduction in intraocular pressure, comprising administering an intraocular formulation comprising a therapeutically effective amount of norketotifen for the reduction of intraocular pressure to the eye of the mammal in need thereof, wherein the intraocular formulation comprises about 0.02 wt % to about 1.0 wt % norketotifen or a salt or an isomer thereof, wherein the amount of norketotifen is calculated as the norketotifen free base, wherein the intraocular formulation is free from any added preservative, wherein the intraocular formulation is self-preserving, wherein the mammal has glaucoma with high intraocular pressure.